"The company is enrolling for a Diabetic Foot Ulcer trial, and has an FDA cleared IND Phase 2 clinical trial of CYP-001 in patients with Graft versus Host Disease underway and a planned collaboration for new renal transplantation clinical trial, to be funded by Leiden University Medical Center"
I like your positive outlook bedger, but the last info on the GVHD trial being underway already is new. Has it already started recruiting? Or is it still in the to do list like it was last year, and expected to begin in end 2022, no, sorry early 2023, no more like mid 2023 if they have enough cash?
I'd love to see more info if you have it rather than rely on the rubbish shareholders have been given to date.
- Forums
- ASX - By Stock
- CYP
- At $24 million mkt cap CYP is a stupidly cheap stock.....by any measure
At $24 million mkt cap CYP is a stupidly cheap stock.....by any measure, page-13
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
26.0¢ |
Change
0.010(4.00%) |
Mkt cap ! $46.70M |
Open | High | Low | Value | Volume |
24.5¢ | 26.5¢ | 24.5¢ | $22.36K | 88.15K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 4125 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 0.250 |
2 | 31297 | 0.245 |
5 | 114215 | 0.240 |
2 | 121276 | 0.235 |
2 | 15173 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 4125 | 2 |
0.295 | 183892 | 1 |
0.300 | 85000 | 2 |
0.310 | 16591 | 3 |
0.345 | 6124 | 1 |
Last trade - 15.55pm 10/07/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online